Colorectal Cancer Association of Canada - CCAC
Home

News and Resources > News  

02/02/17

Immunotherapy, Treatment of the Year

Immunotherapy, Treatment of the Year

Clinical Cancer Advances, ASCO’s annual report highlighs the most significant advances in cancer research over the past year, as chosen by leading experts in the field.

ASCO has named Immunotherapy as Cancer Advance of the Year.

Immunotherapy continues to be a promising treatment for patients and research is helping oncologists understand when and how these treatments work best.

To learn more about the current state of oncology research, recent advances that can benefit patients today, where cancer research is heading, and ASCO’s 2017 Advance of the Year, read the full report.

Full report: http://www.asco.org/research-progress/reports-studies/clinical-cancer-advances/advance-year-immunotherapy-20


Bookmark and Share

Source: http://www.asco.org/research-progress/reports-studies/clinical-cancer-advances/advance-year-immunotherapy-20